Circulating Tumor Cell (CTC) Diagnostics Market Report

Global and Region Circulating Tumor Cell (CTC) Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：147
  • REPORT CODE：GMM1017821
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.

    The report details the trend, potential and market size of Circulating Tumor Cell (CTC) Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Tumor Cell (CTC) Diagnosticsmarket, defines the market attractiveness level of Circulating Tumor Cell (CTC) Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Circulating Tumor Cell (CTC) Diagnostics industry, describes the types of Circulating Tumor Cell (CTC) Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Tumor Cell (CTC) Diagnostics market and the development prospects and opportunities of Circulating Tumor Cell (CTC) Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Tumor Cell (CTC) Diagnostics market in Chapter 13.

    By Player:

    • QIAGEN Hannover GmbH (Germany)

    • RARECELLS SAS (Italy)

    • Biofluidica Microtechnologies LLC (US)

    • ScreenCell (France)

    • Janssen Diagnostics LLC (US)

    • Clearbridge Biomedics (Singapore)

    By Type:

    • CTC Enrichment

    • CTC Detection

    By End-User:

    • Hospitals and clinics

    • Pharmaceuticals and biotechnology companies

    • Academic research institutes

    • CROs

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Circulating Tumor Cell (CTC) Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Circulating Tumor Cell (CTC) Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Circulating Tumor Cell (CTC) Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Circulating Tumor Cell (CTC) Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Circulating Tumor Cell (CTC) Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.2 United States Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.4 China Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.5 Japan Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.6 India Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Circulating Tumor Cell (CTC) Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Circulating Tumor Cell (CTC) Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2022-2028)

    9 Global Circulating Tumor Cell (CTC) Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CTC Enrichment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTC Detection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmaceuticals and biotechnology companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Academic research institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global CROs Consumption and Growth Rate (2017-2022)

    10 Global Circulating Tumor Cell (CTC) Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CTC Enrichment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CTC Detection Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmaceuticals and biotechnology companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Academic research institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global CROs Consumption Forecast and Growth Rate (2022-2028)

    11 Global Circulating Tumor Cell (CTC) Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Circulating Tumor Cell (CTC) Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Circulating Tumor Cell (CTC) Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Circulating Tumor Cell (CTC) Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Circulating Tumor Cell (CTC) Diagnostics Market Competitive Analysis

    • 14.1 QIAGEN Hannover GmbH (Germany)

      • 14.1.1 QIAGEN Hannover GmbH (Germany) Company Details

      • 14.1.2 QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • 14.2 RARECELLS SAS (Italy)

      • 14.2.1 RARECELLS SAS (Italy) Company Details

      • 14.2.2 RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • 14.3 Biofluidica Microtechnologies LLC (US)

      • 14.3.1 Biofluidica Microtechnologies LLC (US) Company Details

      • 14.3.2 Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • 14.4 ScreenCell (France)

      • 14.4.1 ScreenCell (France) Company Details

      • 14.4.2 ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • 14.5 Janssen Diagnostics LLC (US)

      • 14.5.1 Janssen Diagnostics LLC (US) Company Details

      • 14.5.2 Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • 14.6 Clearbridge Biomedics (Singapore)

      • 14.6.1 Clearbridge Biomedics (Singapore) Company Details

      • 14.6.2 Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Circulating Tumor Cell (CTC) Diagnostics

    • Figure Circulating Tumor Cell (CTC) Diagnostics Picture

    • Table Global Circulating Tumor Cell (CTC) Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cell (CTC) Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cell (CTC) Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Country (2017-2022)

    • Figure United States Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Circulating Tumor Cell (CTC) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Enrichment Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Detection Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceuticals and biotechnology companies Consumption and Growth Rate (2017-2022)

    • Figure Global Academic research institutes Consumption and Growth Rate (2017-2022)

    • Figure Global CROs Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Enrichment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Detection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceuticals and biotechnology companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic research institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CROs Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Circulating Tumor Cell (CTC) Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Circulating Tumor Cell (CTC) Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table QIAGEN Hannover GmbH (Germany) (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • Table RARECELLS SAS (Italy) (Foundation Year, Company Profile and etc.)

    • Table RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • Table Biofluidica Microtechnologies LLC (US) (Foundation Year, Company Profile and etc.)

    • Table Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • Table ScreenCell (France) (Foundation Year, Company Profile and etc.)

    • Table ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • Table Janssen Diagnostics LLC (US) (Foundation Year, Company Profile and etc.)

    • Table Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Product and Service

    • Table Clearbridge Biomedics (Singapore) (Foundation Year, Company Profile and etc.)

    • Table Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US